Annexin A1 promotes timely resolution of inflammation in murine gout

European Journal of Immunology

Volumn 47, Issue 3, 2017, Pages 585-596

  Galvão, Izabela ^a   Vago, Juliana P ^a   Barroso, Livia C ^a   Tavares, Luciana P ^a   Queiroz Junior, Celso M ^a   Costa, Vivian V ^a   Carneiro, Fernanda S ^a   Ferreira, Tatiana P ^b   Silva, Patricia M R ^b   Amaral, Flávio A ^a   Sousa, Lirlândia P ^a   Teixeira, Mauro M ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Annexin A1; Gout; Inflammation; Neutrophils; Resolution of inflammation

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTISERUM; BOC 1; CASPASE INHIBITOR; CXCL1 CHEMOKINE; D 3428; INTERLEUKIN 1BETA; LIPOCORTIN 1; PEPTIDE AC [2-26]; RECEPTOR BLOCKING AGENT; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; WRW 4; ZVAD FMK; ANNEXIN A1 PEPTIDE (2-26); BLOCKING ANTIBODY; OLIGOPEPTIDE; PEPTIDE; T-BUTYLOXYCARBONYL-METHIONYL-LEUCYL-PHENYLALANINE; TRYPTOPHYL-ARGINYL-TRYPTOPHYL-TRYPTOPHYL-TRYPTOPHYL-TRYPTOPHANAMIDE; URIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPERIMENTAL INFLAMMATION; GOUT; HISTOPATHOLOGY; MALE; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING; ANIMAL; C57BL MOUSE; CELL MOTION; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; JOINT; KNOCKOUT MOUSE; METABOLISM; PHAGOCYTOSIS; PHYSIOLOGY;

ANIMALS; ANNEXIN A1; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, BLOCKING; APOPTOSIS; CELL MOVEMENT; DISEASE MODELS, ANIMAL; GOUT; HUMANS; INFLAMMATION; JOINTS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; OLIGOPEPTIDES; PEPTIDES; PHAGOCYTOSIS; URIC ACID;

EID: 85010282188     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201646551     Document Type: Article

References (61)

1. Robinson, P. C. and Horsburgh, S., Gout: joints and beyond, epidemiology, clinical features, treatment and co-morbidities. Maturitas 2014. 78: 245–251.
2. Martin, W. J., Walton, M. and Harper, J., Resident macrophages initiating and driving inflammation in a monosodium urate monohydrate crystal-induced murine peritoneal model of acute gout. Arthritis Rheum. 2009. 60: 281–289.
3. Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. and Tschopp, J., Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006. 440: 237–241.
4. Amaral, F. A., Costa, V. V., Tavares, L. D., Sachs, D., Coelho, F. M., Fagundes, C. T., Soriani, F. M. et al., NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B(4) in a murine model of gout. Arthritis Rheum. 2012. 64: 474–484.
5. Popa-Nita, O. and Naccache, P. H., Crystal-induced neutrophil activation. Immunol. Cell Biol. 2010. 88: 32–40.
6. Steiger, S. and Harper, J. L., Mechanisms of spontaneous resolution of acute gouty inflammation. Curr. Rheumatol. Rep. 2014. 16: 392.
7. Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A., Perretti, M. et al., Resolution of inflammation: state of the art, definitions and terms. FASEB J. 2007. 21: 325–332.
8. Rossi, A. G., Hallett, J. M., Sawatzky, D. A., Teixeira, M. M. and Haslett, C., Modulation of granulocyte apoptosis can influence the resolution of inflammation. Biochem. Soc. Trans. 2007. 35: 288–291.
9. Perretti, M. and D'Acquisto, F., Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat. Rev. Immunol. 2009. 9: 62–70.
10. Perretti, M. and Flower, R. J., Annexin 1 and the biology of the neutrophil. J. Leukoc. Biol. 2004. 76: 25–29.
11. Sugimoto, M. A., Vago, J. P., Teixeira, M. M. and Sousa, L. P., Annexin A1 and the resolution of inflammation: modulation of neutrophil recruitment, apoptosis, and clearance. J. Immunol. Res. 2016. 2016: 8239258.
12. Hannon, R., Croxtall, J. D., Getting, S. J., Roviezzo, F., Yona, S., Paul-Clark, M. J., Gavins, F. N. et al., Aberrant inflammation and resistance to glucocorticoids in annexin 1-/- mouse. FASEB J. 2003. 17: 253–255.
13. Liu-Bryan, R., Scott, P., Sydlaske, A., Rose, D. M. and Terkeltaub, R., Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum. 2005. 52: 2936–2946.
14. Landis, R. C., Yagnik, D. R., Florey, O., Philippidis, P., Emons, V., Mason, J. C. and Haskard, D. O., Safe disposal of inflammatory monosodium urate monohydrate crystals by differentiated macrophages. Arthritis Rheum. 2002. 46: 3026–3033.
15. Yona, S., Buckingham, J. C., Perretti, M. and Flower, R. J., Stimulus-specific defect in the phagocytic pathways of annexin 1 null macrophages. Br. J. Pharmacol. 2004. 142: 890–898.
16. Rose, D. M. and Liu-Bryan, R., Innate immunity in triggering and resolution of acute gouty inflammation. Curr. Rheumatol. Rep. 2006. 8: 209–214.
17. Bannenberg, G. L., Chiang, N., Ariel, A., Arita, M., Tjonahen, E., Gotlinger, K. H., Hong, S. and Serhan, C. N., Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol. 2005. 174: 4345–4355.
18. Chiang, N., Shinohara, M., Dalli, J., Mirakaj, V., Kibi, M., Choi, A. M. and Serhan, C. N., Inhaled carbon monoxide accelerates resolution of inflammation via unique proresolving mediator-heme oxygenase-1 circuits. J. Immunol. 2013. 190: 6378–6388.
19. Dalli, J., Consalvo, A. P., Ray, V., Di Filippo, C., D'Amico, M., Mehta, N. and Perretti, M., Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor. J. Immunol. 2013. 190: 6478–6487.
20. Vago, J. P., Tavares, L. P., Garcia, C. C., Lima, K. M., Perucci, L. O., Vieira, E. L., Nogueira, C. R. et al., The role and effects of glucocorticoid-induced leucine zipper in the context of inflammation resolution. J. Immunol. 2015. 194: 4940–4950.
21. Bandeira-Melo, C., Bonavita, A. G., Diaz, B. L., PM, E. S., Carvalho, V. F., Jose, P. J., Flower, R. J. et al., A novel effect for annexin 1-derived peptide ac2-26: reduction of allergic inflammation in the rat. J. Pharmacol. Exp. Ther. 2005. 313: 1416–1422.
22. Damazo, A. S., Yona, S., D'Acquisto, F., Flower, R. J., Oliani, S. M. and Perretti, M., Critical protective role for annexin 1 gene expression in the endotoxemic murine microcirculation. Am. J. Pathol. 2005. 166: 1607–1617.
23. Vago, J. P., Nogueira, C. R., Tavares, L. P., Soriani, F. M., Lopes, F., Russo, R. C., Pinho, V. et al., Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis. J. Leukoc. Biol. 2012. 92: 249–258.
24. Babbin, B. A., Laukoetter, M. G., Nava, P., Koch, S., Lee, W. Y., Capaldo, C. T., Peatman, E. et al., Annexin A1 regulates intestinal mucosal injury, inflammation, and repair. J. Immunol. 2008. 181: 5035–5044.
25. Leoni, G., Neumann, P. A., Kamaly, N., Quiros, M., Nishio, H., Jones, H. R., Sumagin, R. et al., Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair. J. Clin. Invest. 2015. 125: 1215–1227.
26. Vong, L., D'Acquisto, F., Pederzoli-Ribeil, M., Lavagno, L., Flower, R. J., Witko-Sarsat, V. and Perretti, M., Annexin 1 cleavage in activated neutrophils: a pivotal role for proteinase 3. J. Biol. Chem. 2007. 282: 29998–30004.
27. Rescher, U., Goebeler, V., Wilbers, A. and Gerke, V., Proteolytic cleavage of annexin 1 by human leukocyte elastase. Biochim. Biophys. Acta 2006. 1763: 1320–1324.
28. Alessandri, A. L., Sousa, L. P., Lucas, C. D., Rossi, A. G., Pinho, V. and Teixeira, M. M., Resolution of inflammation: mechanisms and opportunity for drug development. Pharmacol. Ther. 2013. 139: 189–212.
29. Perretti, M., Chiang, N., La, M., Fierro, I. M., Marullo, S., Getting, S. J., Solito, E. et al., Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat. Med. 2002. 8: 1296–1302.
30. Bena, S., Brancaleone, V., Wang, J. M., Perretti, M. and Flower, R. J., Annexin A1 interaction with the FPR2/ALX receptor: identification of distinct domains and downstream associated signaling. J. Biol. Chem. 2012. 287: 24690–24697.
31. Cooray, S. N., Gobbetti, T., Montero-Melendez, T., McArthur, S., Thompson, D., Clark, A. J., Flower, R. J. et al., Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses. Proc. Natl. Acad. Sci. USA 2013. 110: 18232–18237.
32. Damazo, A. S., Yona, S., Flower, R. J., Perretti, M. and Oliani, S. M., Spatial and temporal profiles for anti-inflammatory gene expression in leukocytes during a resolving model of peritonitis. J. Immunol. 2006. 176: 4410–4418.
33. Gavins, F. N., Hughes, E. L., Buss, N. A., Holloway, P. M., Getting, S. J. and Buckingham, J. C., Leukocyte recruitment in the brain in sepsis: involvement of the annexin 1-FPR2/ALX anti-inflammatory system. FASEB. J. 2012. 26: 4977–4989.
34. Yang, Y. H., Morand, E. F., Getting, S. J., Paul-Clark, M., Liu, D. L., Yona, S., Hannon, R. et al., Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen-induced arthritis. Arthritis Rheum. 2004. 50: 976–984.
35. Gimenes, A. D., Andrade, T. R., Mello, C. B., Ramos, L., Gil, C. D. and Oliani, S. M., Beneficial effect of annexin A1 in a model of experimental allergic conjunctivitis. Exp. Eye Res. 2015. 134: 24–32.
36. Locatelli, I., Sutti, S., Jindal, A., Vacchiano, M., Bozzola, C., Reutelingsperger, C., Kusters, D. et al., Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice. Hepatology 2014. 60: 531–544.
37. Chatterjee, B. E., Yona, S., Rosignoli, G., Young, R. E., Nourshargh, S., Flower, R. J. and Perretti, M., Annexin 1-deficient neutrophils exhibit enhanced transmigration in vivo and increased responsiveness in vitro. J. Leukoc. Biol. 2005. 78: 639–646.
38. Chiang, N., Schwab, J. M., Fredman, G., Kasuga, K., Gelman, S. and Serhan, C. N., Anesthetics impact the resolution of inflammation. PLoS One 2008. 3: e1879.
39. Vago, J. P., Tavares, L. P., Sugimoto, M. A., Lima, G. L., Galvao, I., de Caux, T. R., Lima, K. M. et al., Proresolving actions of synthetic and natural protease inhibitors are mediated by annexin A1. J. Immunol. 2016. 196: 1922–1932.
40. Solito, E., Kamal, A., Russo-Marie, F., Buckingham, J. C., Marullo, S. and Perretti, M., A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophils. FASEB. J. 2003. 17: 1544–1546.
41. Blume, K. E., Soeroes, S., Keppeler, H., Stevanovic, S., Kretschmer, D., Rautenberg, M., Wesselborg, S. et al., Cleavage of annexin A1 by ADAM10 during secondary necrosis generates a monocytic "find-me" signal. J. Immunol. 2012. 188: 135–145.
42. Blume, K. E., Soeroes, S., Waibel, M., Keppeler, H., Wesselborg, S., Herrmann, M., Schulze-Osthoff, K. et al., Cell surface externalization of annexin A1 as a failsafe mechanism preventing inflammatory responses during secondary necrosis. J. Immunol. 2009. 183: 8138–8147.
43. Maderna, P., Yona, S., Perretti, M. and Godson, C., Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac(2–26). J. Immunol. 2005. 174: 3727–3733.
44. Dalli, J., Jones, C. P., Cavalcanti, D. M., Farsky, S. H., Perretti, M. and Rankin, S. M., Annexin A1 regulates neutrophil clearance by macrophages in the mouse bone marrow. FASEB. J. 2012. 26: 387–396.
45. Pederzoli-Ribeil, M., Maione, F., Cooper, D., Al-Kashi, A., Dalli, J., Perretti, M. and D'Acquisto, F., Design and characterization of a cleavage-resistant Annexin A1 mutant to control inflammation in the microvasculature. Blood 2010. 116: 4288–4296.
46. Hayhoe, R. P., Kamal, A. M., Solito, E., Flower, R. J., Cooper, D. and Perretti, M., Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. Blood 2006. 107: 2123–2130.
47. Peshavariya, H. M., Taylor, C. J., Goh, C., Liu, G. S., Jiang, F., Chan, E. C. and Dusting, G. J., Annexin peptide Ac2-26 suppresses TNFalpha-induced inflammatory responses via inhibition of Rac1-dependent NADPH oxidase in human endothelial cells. PLoS One 2013. 8: e60790.
48. Girol, A. P., Mimura, K. K., Drewes, C. C., Bolonheis, S. M., Solito, E., Farsky, S. H., Gil, C. D. et al., Anti-inflammatory mechanisms of the annexin A1 protein and its mimetic peptide Ac2–26 in models of ocular inflammation in vivo and in vitro. J. Immunol. 2013. 190: 5689–5701.
49. Lim, L. H., Solito, E., Russo-Marie, F., Flower, R. J. and Perretti, M., Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1. Proc. Natl. Acad. Sci. USA 1998. 95: 14535–14539.
50. Perretti, M. and Dalli, J., Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics. Br. J. Pharmacol. 2009. 158: 936–946.
51. Sousa, L. P., Alessandri, A. L., Pinho, V. and Teixeira, M. M., Pharmacological strategies to resolve acute inflammation. Curr. Opin. Pharmacol. 2013. 13: 625–631.
52. Fullerton, J. N. and Gilroy, D. W., Resolution of inflammation: a new therapeutic frontier. Nat. Rev. Drug Discov. 2016. 15: 551–567.
53. Ferreira, S. H., Cunha, F. Q., Lorenzetti, B. B., Michelin, M. A., Perretti, M., Flower, R. J. and Poole, S., Role of lipocortin-1 in the anti-hyperalgesic actions of dexamethasone. Br. J. Pharmacol. 1997. 121: 883–888.
54. Pei, L., Zhang, J., Zhao, F., Su, T., Wei, H., Tian, J., Li, M. et al., Annexin 1 exerts anti-nociceptive effects after peripheral inflammatory pain through formyl-peptide-receptor-like 1 in rat dorsal root ganglion. Br. J. Anaesth. 2011. 107: 948–958.
55. Headland, S. E., Jones, H. R., Norling, L. V., Kim, A., Souza, P. R., Corsiero, E., Gil, C. D. et al., Neutrophil-derived microvesicles enter cartilage and protect the joint in inflammatory arthritis. Sci. Transl. Med. 2015. 7: 315ra190.
56. Scanu, A., Oliviero, F., Ramonda, R., Frallonardo, P., Dayer, J. M. and Punzi, L., Cytokine levels in human synovial fluid during the different stages of acute gout: role of transforming growth factor beta1 in the resolution phase. Ann. Rheum. Dis. 2012. 71: 621–624.
57. Vieira, A. T., Galvao, I., Macia, L. M., Sernaglia, E. M., Vinolo, M. A., Garcia, C. C., Tavares, L. P. et al., Dietary fiber and the short-chain fatty acid acetate promote resolution of neutrophilic inflammation in a model of gout in mice. J. Leukoc. Biol. 2016. 100: 1–20.
58. Coelho, F. M., Pinho, V., Amaral, F. A., Sachs, D., Costa, V. V., Rodrigues, D. H., Vieira, A. T. et al., The chemokine receptors CXCR1/CXCR2 modulate antigen-induced arthritis by regulating adhesion of neutrophils to the synovial microvasculature. Arthritis. Rheum. 2008. 58: 2329–2337.
59. Sachs, D., Coelho, F. M., Costa, V. V., Lopes, F., Pinho, V., Amaral, F. A., Silva, T. A. et al., Cooperative role of tumour necrosis factor-alpha, interleukin-1beta and neutrophils in a novel behavioural model that concomitantly demonstrates articular inflammation and hypernociception in mice. Br. J. Pharmacol. 2011. 162: 72–83.
60. Sousa, L. P., Lopes, F., Silva, D. M., Tavares, L. P., Vieira, A. T., Rezende, B. M., Carmo, A. F. et al., PDE4 inhibition drives resolution of neutrophilic inflammation by inducing apoptosis in a PKA-PI3K/Akt-dependent and NF-kappaB-independent manner. J. Leukoc. Biol. 2010. 87: 895–904.
61. Queiroz-Junior, C. M., Madeira, M. F., Coelho, F. M., Costa, V. V., Bessoni, R. L., Sousa, L. F., Garlet, G. P. et al., Experimental arthritis triggers periodontal disease in mice: involvement of TNF-alpha and the oral Microbiota. J. Immunol. 2011. 187: 3821–3830.